Dr. Nicole Jasmyn Bright, DO

Dr. Bright practices at Delaware Outpatient Center for Surgery - HOPD in Newark, Delaware.

Dr. Bright's NPI, 1578722856, was assigned on June 3, 2008. Dr. Bright graduated from Pcom in 2006. Dr. Bright holds Pennsylvania license OT011840.

Dr. Bright's primary practice is Delaware Outpatient Center for Surgery - HOPD, at 774 Christiana Rd, Newark, DE 19713.

Dr. Bright's primary practice is Delaware Outpatient Center for Surgery - HOPD in Newark, Delaware. Dr. Bright is also affiliated with Bayhealth Hospital, Kent Campus. The medical group on file is Burke Dermatology. Dmand AI also links Dr. Bright to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bright practices, 7 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bright's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bright is board certified in dermatology by the AOA Board of Dermatology. Dr. Bright is licensed in Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Bright treats.

CMS data shows 7,679 Medicare services from Dr. Bright across 30 procedure codes in 2024, for 1,829 Medicare patients. Medicare paid $549,562 for them. Every service was in an office.

CMS counts 1,829 Medicare patients who saw Dr. Bright in 2024. The largest group is 65 to 74, with 830 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bright's median patient age at 71, with 58% women.

In 2024, Dr. Bright wrote 2,890 Medicare Part D claims for 965 patients. 82% of them were for generic drugs. CMS names the drug for 2,624 of them, across 46 drugs with 11 or more claims each, at $2,328,447 in total drug cost. In 2023, CMS named 2,248 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Bright for performance year 2024, reported as part of a group. Dr. Bright accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 725 procedures of skin biopsy by Dr. Bright, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 1,363 general payments to Dr. Bright from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Sanofi and Genzyme US Companies paid the most, $4,333.

Dr. Bright graduated from Pcom in 2006. Dr. Bright is a member of AOA.

Dr. Bright is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Highmark. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.